苯二氮卓类药物市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

苯二氮卓类药物市场按产品(阿普唑仑、地西泮、劳拉西泮、氯硝西泮)、应用、作用时间和地理位置进行细分。

市场快照

Benzodiazepine Drugs Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 2.4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,研究的苯二氮卓类药物市场预计将以 2.4% 的复合年增长率增长。苯二氮卓类药物是一类精神活性药物,用于治疗焦虑症、失眠症、恐慌症、癫痫发作和戒酒等疾病。苯二氮卓类药物通过增强神经递质 GABA(γ-氨基丁酸)的作用产生镇静作用。苯二氮卓类药物是世界各地广泛使用的药物,有助于减少焦虑症、癫痫发作、诱导睡眠,还可用于手术或全身麻醉前的镇静作用。老年人口的增加、压力大的生活方式、日常习惯是精神障碍的主要因素,这些因素会导致焦虑、躁狂和恐慌症。由于焦虑症、癫痫发作、失眠症的患病率增加,以及对预防压力和相关疾病的关注度增加,苯二氮卓类药物市场正在迅速扩大。由于阿普唑仑在焦虑、恐慌症中的广泛应用,预计将扩大增长。然而,滥用苯二氮卓类药物可能会限制该市场的增长。

报告范围

苯二氮卓类药物是一类精神活性药物,用于治疗焦虑症、失眠症、恐慌症、癫痫发作和戒酒等疾病。苯二氮卓类药物按产品、应用、作用时间和地理位置进行细分。

By Product
Alprazolam
Diazepam
Lorazepam
Clonazepam
By Application
Anxiety disorders
Seizures
Insomnia
Alcohol Withdrawal
By Time of Action
Ultra-short Acting
Short Acting
Long Acting
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

焦虑症细分市场有望在苯二氮卓类药物中占据最大市场份额

预计焦虑部分将在预测期内占据市场的主要份额。根据世界卫生组织 (WHO) 的估计,2015 年全球患有焦虑症的人数为 2.64 亿,自 2005 年以来增长了 14.9%,因为人口增长和老龄化的结果,估计为 3.6%。焦虑症在女性中比男性更常见(在全球范围内,女性为 4.6%,而男性为 2.6%)。

2017 年,抗抑郁药物和焦虑治疗药物需求的增长以及投资开发新型焦虑药物的公司数量增加,推动了市场收入的增长,2017 年焦虑细分市场的收入份额合计超过 60%。焦虑是 2017 年全球苯二氮卓类药物市场的主要部分,预计在预测期内将保持不变。

Regional

北美预计将主导市场,并预计在预测期内做同样的事情

由于该地区获得更多 FDA 批准,预计北美将在全球苯二氮卓类药物市场占据主导地位。根据美国焦虑症和抑郁症协会 (ADAA) 的数据,美国每年约有 4000 万成年人患有焦虑症,其中只有 36.9% 接受治疗。精神卫生保健服务的发展和对焦虑症认识的提高是广泛性焦虑症(GAD)诊断增加的原因。由于老年人口的增长正在提高墨西哥的焦虑症诊断率,从而直接增加了对认知行为疗法 (CBT) 和广泛性焦虑症 (GAD) 药物等物理疗法的需求。

Benzodiazepine Drugs Market Share

竞争格局

苯二氮卓类药物市场竞争适度,由几个参与者组成。在市场份额方面,更多的玩家目前正在主导市场。目前主导市场的一些公司是辉瑞公司、F. Hoffmann-La Roche Ltd.、Bausch Health Companies, Inc.、Mylan NV、Teva Pharmaceutical Industries Ltd.、H.Lundbeck A/S、Amneal Pharmaceuticals LLC 、Sun Pharmaceutical Industries Ltd.、Apotex Inc. 和 Aurobindo Pharma 等。

竞争格局

苯二氮卓类药物市场竞争适度,由几个参与者组成。在市场份额方面,更多的玩家目前正在主导市场。目前主导市场的一些公司是辉瑞公司、F. Hoffmann-La Roche Ltd.、Bausch Health Companies, Inc.、Mylan NV、Teva Pharmaceutical Industries Ltd.、H.Lundbeck A/S、Amneal Pharmaceuticals LLC 、Sun Pharmaceutical Industries Ltd.、Apotex Inc. 和 Aurobindo Pharma 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Prevalence of Anxiety disorders, Seizures and Insomnia Diseases

      2. 4.2.2 Rise in Adoption of Generic Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Misuse of Benzodiazepine Drugs

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Alprazolam

      2. 5.1.2 Diazepam

      3. 5.1.3 Lorazepam

      4. 5.1.4 Clonazepam

    2. 5.2 By Application

      1. 5.2.1 Anxiety disorders

      2. 5.2.2 Seizures

      3. 5.2.3 Insomnia

      4. 5.2.4 Alcohol Withdrawal

    3. 5.3 By Time of Action

      1. 5.3.1 Ultra-short Acting

      2. 5.3.2 Short Acting

      3. 5.3.3 Long Acting

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Amneal Pharmaceuticals LLC

      2. 6.1.2 Apotex Inc.

      3. 6.1.3 Aurobindo Pharma

      4. 6.1.4 Bausch Health Companies, Inc.

      5. 6.1.5 F.Hoffmann-La Roche Ltd.

      6. 6.1.6 H.Lundbeck A/S

      7. 6.1.7 Mylan, N.V.

      8. 6.1.8 Pfizer Inc.

      9. 6.1.9 Sun Pharmaceutical Industries Ltd.

      10. 6.1.10 Teva Pharmaceutical Industries Ltd.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Benzodiazepine Drugs Market market is studied from 2018 - 2026.

The Benzodiazepine Drugs Market is growing at a CAGR of 2.4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Pfizer Inc., F. Hoffmann-La Roche Ltd, Bausch Health Companies, Inc, Mylan N.V., Teva Pharmaceutical Industries Ltd are the major companies operating in Benzodiazepine Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!